臍帶血庫服務市場：按類型和地區分類

Cord Blood Banking Services Market, By Type (Public Cord Blood Banking Services, Private Cord Blood Banking Services), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，臍帶血庫服務市場規模將達到 404.5 億美元，到 2033 年將達到 620.3 億美元。預計 2026 年至 2033 年的複合年成長率將達到 6.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	404.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	620.3億美元

臍帶血庫是收集和儲存嬰兒出生後臍帶血的系統。臍帶血是指嬰兒臍帶剪斷後剩餘的血液。臍帶血富含幹細胞。幹細胞極為珍貴，因為它們可以幫助治療許多危及生命的疾病。對健康人來說，產生幹細胞不成問題。然而，不幸的是，有些人由於嚴重的疾病而無法產生足夠的健康幹細胞。對這些人來說，臍帶血來源的幹細胞可以拯救生命。臍帶血中含有骨髓中也存在的特殊類型的幹細胞，這些幹細胞有助於增強免疫系統。這些細胞的獨特之處在於它們可以分化成各種類型的血球。臍帶血庫的存在就是為了收集和儲存這些幹細胞。醫療專業人員使用臍帶血來源的幹細胞為患者進行移植和研究。在臍帶血庫登記完全出於自願。需要幹細胞移植的人可以從嬰兒的臍帶血中受益。移植後，幹細胞有助於生成新的健康細胞。幹細胞移植可以幫助治療白血病和淋巴瘤等癌症、需要移植的骨髓疾病、鐮狀狀細胞貧血等貧血以及某些免疫系統疾病。研究人員正在探索臍帶血如何幫助治療帕金森氏症和糖尿病等其他危及生命的疾病。臍帶血庫會對收到的臍帶血進行分析和處理，並賦予其特定的特徵。如果這些特徵與捐贈者和受體的特徵相匹配，那麼捐贈的幹細胞就能幫助患者的免疫系統對抗疾病。

市場動態

慢性病盛行率上升、主要市場參與者的併購以及捐血中心數量的增加預計將推動全球臍帶血庫服務市場的成長。例如，2021年4月，為藥物和診斷開發提供研究模型和服務的BioIVT LLC在馬薩諸塞州梅德福的塔夫茨大學校園內開設了一家新的捐血中心，以支持從事新冠病毒、細胞療法和基因療法研究的學術和製藥研究人員。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告根據以下參數介紹了全球臍帶血庫服務市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球臍帶血庫服務市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用分析全球臍帶血庫服務市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第6章競爭情勢

China Cord Blood Corporation
Cord Blood America, Inc.
CBR Systems, Inc.
Cordlife Group Ltd.
Cryo-Cell International, Inc.
StemCyte, Inc.
Americord Registry
Cryo-Save Group AV
NeoStem, Inc.
Blood Centers of America
ViaCord, Inc.

第7章

調查方法
關於本公司

簡介目錄

Product Code: CMI3913

Cord Blood Banking Services Market is estimated to be valued at USD 40.45 Bn in 2026 and is expected to reach USD 62.03 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 40.45 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 62.03 Bn

Cord blood banking is when a baby's umbilical cord blood is collected and stored after delivery. Cord blood is what's left inside a baby's umbilical cord after its cut. Umbilical cord blood is rich in stem cells. Stem cells are valuable because they help treat many life-threatening diseases. For most healthy people, making stem cells isn't a problem. Unfortunately, some people don't make enough healthy stem cells due to a severe medical condition or disease. The stem cells from cord blood can be lifesaving for these people. Cord blood contains a special type of stem cell found in bone marrow that can help strengthen the immune system. These cells are unique because they can mature into different types of blood cells. Cord blood banks exist to collect and store these stem cells. Healthcare providers use cord blood stem cells for transplants in sick people or for medical research. Cord blood banking is entirely optional. People who need stem cell transplants benefit from a baby's cord blood. Once stem cells are transplanted into those individuals, they help make new, healthy cells. Stem cell transplants help people with Cancers like leukemia and lymphoma; Bone marrow diseases requiring a transplant; Anemia like sickle cell disease; certain immune system disorders. Researchers are studying cord blood to see how it can help treat other life-threatening conditions like Parkinson's disease and diabetes. Cord blood banks analyze and process the cord blood it receive. It assigns the blood certain characteristics. When these characteristics are matched for donor and receiver, donated stem cells can help a sick person's immune system fight diseases.

Market Dynamics

Increasing prevalence of chronic diseases, mergers and acquisitions by key market players, and increasing number of blood donor centers are expected to drive the global cord blood banking services market's growth. For instance, in April 2021, BioIVT LLC a provider of research models and services for drug and diagnostic development, started its new blood donor center on the Tufts University campus in Medford, Massachusetts, U.S., to support academic and pharmaceutical researchers involved in COVID-19, cell, and gene therapy research.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cord blood banking services market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., StemCyte, Inc., Americord Registry, Cryo-Save Group AV, NeoStem, Inc., Blood Centers of America, and ViaCord, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cord blood banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cord blood banking services market.

Market Segmentation

Global Cord Blood Banking Services Market, By Type (Revenue, USD Bn, 2021 - 2033)
Public Cord Blood Banking Services
Private Cord Blood Banking Services
Global Cord Blood Banking Services Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
China Cord Blood Corporation
Cord Blood America, Inc.
CBR Systems, Inc.
Cordlife Group Ltd.
Cryo-Cell International, Inc.
StemCyte, Inc.
Americord Registry
Cryo-Save Group AV
NeoStem, Inc.
Blood Centers of America
ViaCord, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Cord Blood Banking Services Market, By Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Public Cord Blood Banking Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Private Cord Blood Banking Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Cord Blood Banking Services Market, By Region, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

China Cord Blood Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cord Blood America, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CBR Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cordlife Group Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cryo-Cell International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
StemCyte, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Americord Registry
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cryo-Save Group AV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NeoStem, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Blood Centers of America
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ViaCord, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies